selected publications
- Wall Street's perspective on oncology drug development. Clinical advances in hematology & oncology : H&O. 2007 Academic Article GET IT
- v-Crk, an effector of the nerve growth factor signaling pathway, delays apoptotic cell death in neurotrophin-deprived PC12 cells. Cell death and differentiation. 1997 Academic Article GET IT
-
Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways.
Molecular and cellular biology.
1994
Academic Article
GET IT
Times cited: 81